Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Preferred Dividend Payments (2023 - 2025)

Historic Preferred Dividend Payments for TriSalus Life Sciences (TLSI) over the last 3 years, with Q3 2025 value amounting to $11.9 million.

  • TriSalus Life Sciences' Preferred Dividend Payments rose 138779.58% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year increase of 34168.49%. This contributed to the annual value of $3.2 million for FY2024, which is 15341.81% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Preferred Dividend Payments stood at $11.9 million, which was up 138779.58% from $714000.0 recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Preferred Dividend Payments registered a high of $11.9 million during Q3 2025, and its lowest value of $458000.0 during Q3 2023.
  • Over the past 3 years, TriSalus Life Sciences' median Preferred Dividend Payments value was $800000.0 (recorded in 2023), while the average stood at $2.0 million.
  • Within the past 5 years, the most significant YoY rise in TriSalus Life Sciences' Preferred Dividend Payments was 138779.58% (2025), while the steepest drop was 1111.11% (2025).
  • TriSalus Life Sciences' Preferred Dividend Payments (Quarter) stood at $800000.0 in 2023, then dropped by 2.12% to $783000.0 in 2024, then soared by 1425.8% to $11.9 million in 2025.
  • Its last three reported values are $11.9 million in Q3 2025, $714000.0 for Q2 2025, and $712000.0 during Q1 2025.